|
The Immunohistochemistry Antibody Company
|
|
|
General Cancer Screen 114 Tissue Microarray - LS-SCA114This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SCA114 |
| Product Name: | General Cancer Screen 114 |
| Description: | Various organ tumors |
| Format: | FFPE |
| Category: | Human Multi-Tumor |
| QA/QC: | H&E reviewed |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | No |
| Stage/Grade: | Yes |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 5 µm |
| Cases: | 72 |
| Cores: | 72 |
| Slides Per Set: | 1 |
LS-SCA114 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Abdomen (Abd); Appendix, Vermiform (App); Bladder (Bla); Bone, Femur (Bon); Brain (Brn); Brain, Cerebellum (Brn); Brain, Occipital lobe (Brn); Breast (Bst); Cervix (Cvx); Chest, Wall (Che); Colon (Col); Colon, Hepatic region (Col); Esophagus (Eso); Gallbladder (Gal); Kidney (Kid); Liver (Liv); Lung (Lng); Lymph node (Lym); Lymph node, Clavicle (Lym); Lymph node, Mandible (Lym); Lymph node, Spleen (Lym); Lymph node, Thigh (Lym); Mediastinum (Med); Ovary (Ova); Pancreas (Pnc); Parotid gland (Pdg); Pelvic cavity (Pel); Peritoneal cavity (Plc); Prostate (Pst); Rectum (Rec); Retroperitoneum (Ret); Skin, Chest wall (Skn); Skin, Head (Skn); Small intestine (SmI); Soft tissue, Back (Sft); Soft tissue, Chest wall (Sft); Soft tissue, Leg (Sft); Stomach (Sto); Testis (Tes); Thyroid (Tyd); Tongue (Tng); Uterus (Ute);
LS-SCA114 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | TNM Tumor Classification | Tumor Stage | Tumor Grade |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | M | 65 y | Skin, Head (Skn) | Basal cell carcinoma | Malignant | T2N0M0 | II | |
| 1 | A2 | Human | M | 46 y | Skin, Chest wall (Skn) | Squamous cell carcinoma | Malignant | T3N0M0 | II | 2 |
| 1 | A3 | Human | M | 50 y | Lung (Lng) | Small cell carcinoma | Malignant | T2N1M0 | II | |
| 1 | A4 | Human | F | 69 y | Lung (Lng) | Adenocarcinoma | Malignant | T3N1M0 | IIIA | 3 |
| 1 | A5 | Human | M | 57 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M0 | II | 3 |
| 1 | A6 | Human | M | 56 y | Lung (Lng) | Large cell carcinoma | Malignant | T2N1M0 | II | |
| 1 | A7 | Human | F | 62 y | Lung (Lng) | Bronchioalveolar carcinoma | Malignant | T2N1M0 | II | |
| 1 | A8 | Human | M | 32 y | Testis (Tes) | Seminoma with necrosis | Tumor | T1N0M0 | I | |
| 1 | A9 | Human | M | 50 y | Testis (Tes) | Spermatocytic seminoma | Tumor | T1N0M0 | I | |
| 1 | B1 | Human | M | 30 y | Testis (Tes) | Embryonal carcinoma | Malignant | T2N0M0 | I | |
| 1 | B2 | Human | M | 67 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N0M0 | II | 2-3 |
| 1 | B3 | Human | M | 64 y | Prostate (Pst) | Rhabdomyosarcoma | Malignant | T2bN0M0 | IIIB | |
| 1 | B4 | Human | M | 67 y | Gallbladder (Gal) | Adenocarcinoma | Malignant | T2N0M0 | II | 2 |
| 1 | B5 | Human | F | 53 y | Gallbladder (Gal) | Adenosquamous carcinoma | Malignant | T3N0M0 | IVA | |
| 1 | B6 | Human | F | 35 y | Small intestine (SmI) | Adenocarcinoma | Malignant | T4N0M0 | II | 2 |
| 1 | B7 | Human | F | 71 y | Small intestine (SmI) | Malignant interstitialoma | Malignant | T2bN0M0 | IB | |
| 1 | B8 | Human | M | 64 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T2N0M0 | I | 3 |
| 1 | B9 | Human | F | 12 y | Pancreas (Pnc) | Islet cell carcinoma | Malignant | |||
| 1 | C1 | Human | M | 46 y | Colon, Hepatic region (Col) | Adenocarcinoma | Malignant | T4N0M0 | II | 3 |
| 1 | C2 | Human | M | 54 y | Colon (Col) | Malignant interstitialoma | Malignant | T2N0M0 | IIB | |
| 1 | C3 | Human | M | 60 y | Rectum (Rec) | Adenocarcinoma | Malignant | T3N1M0 | II | 2 |
| 1 | C4 | Human | M | 32 y | Rectum (Rec) | Malignant interstitialoma | Malignant | T1bN0M0 | IIA | |
| 1 | C5 | Human | F | 70 y | Rectum (Rec) | Malignant melanoma | Malignant | |||
| 1 | C6 | Human | M | 50 y | Esophagus (Eso) | Squamous cell carcinoma | Malignant | T2N0M0 | IIA | 2 |
| 1 | C7 | Human | F | 67 y | Esophagus (Eso) | Adenocarcinoma | Malignant | T4N0M0 | III | 3 |
| 1 | C8 | Human | F | 50 y | Appendix, Vermiform (App) | Adenocarcinoma | Malignant | T1N0M0 | I | 1 |
| 1 | C9 | Human | M | 78 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | T2N0M0 | II | 1 |
| 1 | D1 | Human | F | 72 y | Parotid gland (Pdg) | Adenoid cystic carcinoma | Malignant | T2N0M0 | II | |
| 1 | D2 | Human | F | 73 y | Stomach (Sto) | Adenocarcinoma, Mucinous | Malignant | T3N1M0 | IIIA | 3 |
| 1 | D3 | Human | F | 17 y | Liver (Liv) | Hepatoblastoma | Malignant | |||
| 1 | D4 | Human | M | 61 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T2N0M0 | II | 3 |
| 1 | D5 | Human | F | 54 y | Breast (Bst) | Lobular carcinoma in situ | Malignant | TisN0M0 | ||
| 1 | D6 | Human | F | 79 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N1M0 | IIB | |
| 1 | D7 | Human | F | 36 y | Breast (Bst) | Intraductal carcinoma | Malignant | TisN0M0 | ||
| 1 | D8 | Human | F | 50 y | Breast (Bst) | Medullary carcinoma | Malignant | T2N0M0 | IIA | |
| 1 | D9 | Human | F | 48 y | Uterus (Ute) | Endometrioid carcinoma with squamous metaplasia | Malignant | T2N0M0 | II | 2-3 |
| 1 | E1 | Human | F | 39 y | Uterus (Ute) | Clear cell carcinoma | Malignant | T2bN0M0 | IIB | |
| 1 | E2 | Human | F | 45 y | Uterus (Ute) | Leiomyoma | Tumor | |||
| 1 | E3 | Human | F | 36 y | Uterus (Ute) | Squamous cell carcinoma | Malignant | T1bN1M0 | IIIB | 2 |
| 1 | E4 | Human | F | 44 y | Cervix (Cvx) | Adenocarcinoma, Endocervical | Malignant | T1b1N0M0 | IB | 1 |
| 1 | E5 | Human | F | 29 y | Ovary (Ova) | Adenocarcinoma, Mucinous | Malignant | T3N0M0 | III | 3 |
| 1 | E6 | Human | F | 53 y | Ovary (Ova) | Adenocarcinoma, Serous | Malignant | T3N1M0 | IIIC | 3 |
| 1 | E7 | Human | M | 61 y | Mediastinum (Med) | Thymoma, Type B3 | Tumor | T1N0M0 | I | |
| 1 | E8 | Human | F | 33 y | Thyroid (Tyd) | Medullary carcinoma | Malignant | T3N0M0 | II | |
| 1 | E9 | Human | F | 36 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T2aN1M0 | III | |
| 1 | F1 | Human | F | 65 y | Brain (Brn) | Meningioma, Atypical | Tumor | |||
| 1 | F2 | Human | F | 15 y | Brain, Occipital lobe (Brn) | Ependymoma, Malignant | Malignant | |||
| 1 | F3 | Human | M | 55 y | Brain (Brn) | Oligodendroglioma, Anaplastic | Malignant | |||
| 1 | F4 | Human | M | 39 y | Brain, Occipital lobe (Brn) | Glioblastoma | Malignant | |||
| 1 | F5 | Human | M | 30 y | Brain, Cerebellum (Brn) | Medulloblastoma | Malignant | |||
| 1 | F6 | Human | F | 72 y | Bladder (Bla) | Transitional cell carcinoma with squamous metaplasia | Malignant | T2N0M0 | II | |
| 1 | F7 | Human | M | 62 y | Bladder (Bla) | Leiomyosarcoma | Malignant | T2bN0M0 | IB | |
| 1 | F8 | Human | M | 66 y | Kidney (Kid) | Transitional cell carcinoma | Malignant | T1N0M0 | I | 1-2 |
| 1 | F9 | Human | F | 58 y | Kidney (Kid) | Papillary renal cell carcinoma | Malignant | T1N0M0 | I | |
| 1 | G1 | Human | M | 55 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T2N0M0 | II | 1 |
| 1 | G2 | Human | M | 42 y | Lymph node (Lym) | Diffuse B-cell lymphoma | Malignant | |||
| 1 | G3 | Human | M | 25 y | Lymph node, Thigh (Lym) | Diffuse B-cell lymphoma | Malignant | |||
| 1 | G4 | Human | F | 68 y | Lymph node, Mandible (Lym) | Diffuse B-cell lymphoma | Malignant | |||
| 1 | G5 | Human | M | 21 y | Lymph node, Spleen (Lym) | Diffuse B-cell lymphoma | Malignant | |||
| 1 | G6 | Human | M | 53 y | Lymph node, Clavicle (Lym) | Hodgkin's lymphoma | Malignant | |||
| 1 | G7 | Human | M | 78 y | Soft tissue, Chest wall (Sft) | Leiomyosarcoma | Malignant | T1aN0M0 | IIA | |
| 1 | G8 | Human | F | 20 y | Soft tissue, Leg (Sft) | Rhabdomyosarcoma, Embryonic | Malignant | T1aN0M0 | IIIA | |
| 1 | G9 | Human | F | 48 y | Retroperitoneum (Ret) | Rhabdomyosarcoma | Malignant | T2N0M0 | IIB | |
| 1 | H1 | Human | F | 14 y | Retroperitoneum (Ret) | Primitive neuroectodermal tumor (PNET) | Malignant | T2N0M0 | IIIB | |
| 1 | H2 | Human | M | 44 y | Abdomen (Abd) | Clear cell sarcoma | Malignant | T2N0M0 | IIIB | |
| 1 | H3 | Human | F | 3 y | Retroperitoneum (Ret) | Neuroblastoma | Malignant | T2bN0M0 | IIIB | |
| 1 | H4 | Human | F | 48 y | Abdomen (Abd) | Liposarcoma, Mucinous | Malignant | T2bN0M0 | IIB | |
| 1 | H5 | Human | M | 56 y | Pelvic cavity (Pel) | Chordoma | Malignant | |||
| 1 | H6 | Human | M | 59 y | Soft tissue, Back (Sft) | Neurofibroma | Tumor | |||
| 1 | H7 | Human | M | 40 y | Chest, Wall (Che) | Sarcoma, Synovial | Malignant | T2bN0M0 | IIB | |
| 1 | H8 | Human | F | 7 y | Bone, Femur (Bon) | Osteosarcoma | Malignant | T2N0M0 | IIIB | |
| 1 | H9 | Human | M | 60 y | Peritoneal cavity (Plc) | Malignant mesothelioma | Malignant |